Lip GYH - Search Results

1

Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban.

Tepper PG, Mardekian J, Masseria C, Phatak H, Kamble S, Abdulsattar Y, Petkun W, Lip GYH. Tepper PG, et al. Among authors: lip gyh. PLoS One. 2018 Nov 1;13(11):e0205989. doi: 10.1371/journal.pone.0205989. eCollection 2018. PLoS One. 2018. PMID: 30383768 Free PMC article.

2

Antiarrhythmics in atrial fibrillation.

Freestone B, Lip GY. Freestone B, et al. Curr Opin Investig Drugs. 2002 Jan;3(1):84-8. Curr Opin Investig Drugs. 2002. PMID: 12054078 Review.

3

Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratification.

Lane DA, Lip GY. Lane DA, et al. Blood Coagul Fibrinolysis. 2005 Oct;16(7):461-4. doi: 10.1097/01.mbc.0000184739.35347.13. Blood Coagul Fibrinolysis. 2005. PMID: 16175003 No abstract available.

4

Management of atrial fibrillation.

Watson T, Lip GY. Watson T, et al. Herz. 2006 Dec;31(9):849-56. doi: 10.1007/s00059-006-2932-5. Herz. 2006. PMID: 17180647 Review.

5

Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation.

Lip GY, Frison L, Grind M; SPORTIF Investigators. Lip GY, et al. J Intern Med. 2008 Jul;264(1):50-61. doi: 10.1111/j.1365-2796.2007.01909.x. Epub 2008 Feb 4. J Intern Med. 2008. PMID: 18266660 Free article. Clinical Trial.

6

Anticoagulation in atrial fibrillation: the trials and tribulations of keeping within therapeutic range.

Taggar JS, Lip GY. Taggar JS, et al. Curr Med Res Opin. 2008 May;24(5):1455-8. doi: 10.1185/030079908x301875. Epub 2008 Apr 9. Curr Med Res Opin. 2008. PMID: 18402716

7

Atrial fibrillation (chronic).

Boos CJ, Lane DA, Lip GY. Boos CJ, et al. BMJ Clin Evid. 2008 Apr 30;2008:0217. BMJ Clin Evid. 2008. PMID: 19450316 Free PMC article. Review.

8

Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial.

Khoo CW, Lip GY. Khoo CW, et al. Expert Opin Pharmacother. 2010 Mar;11(4):685-7. doi: 10.1517/14656560903530691. Expert Opin Pharmacother. 2010. PMID: 20105114 Clinical Trial.

9

Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients?

Lip GY, Lane DA. Lip GY, et al. Am J Med. 2010 Sep;123(9):785-9. doi: 10.1016/j.amjmed.2010.01.031. Epub 2010 Jul 23. Am J Med. 2010. PMID: 20655037 Review.

10

Stroke prevention in atrial fibrillation patients.

Marinigh R, Lip GY, Lane DA. Marinigh R, et al. Expert Opin Pharmacother. 2010 Oct;11(14):2331-50. doi: 10.1517/14656566.2010.498819. Expert Opin Pharmacother. 2010. PMID: 20718589 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,634 results

Search Page

Filters